Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|16|10|1142-1159

ISSN： 1389-4501

Source： Current Drug Targets, Vol.16, Iss.10, 2015-09, pp. : 1142-1159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignancies of the head and neck: the role for molecular targeted agents

By Agulnik Mark  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions

By  

Current Pharmaceutical Design, Vol. 11, Iss. 2, 2005-01 ,pp. : 265-272

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma

By  

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 181-188

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Agents for the Treatment of Advanced Renal Cell Carcinoma

By  

Current Drug Targets, Vol. 6, Iss. 7, 2005-11 ,pp. : 835-846

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches

By Harris Pamela Jo   Bible Keith C  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1357-1375

Informa Healthcare

Access to resources Recommend Favorite